These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2081275)

  • 1. Double-blind trial of bestatin in HIV-positive patients.
    Hørding M; Gøtzsche PC; Dalh Christensen L; Bygbjerg IC; Faber V
    Biomed Pharmacother; 1990; 44(9):475-8. PubMed ID: 2081275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of immunomodulating effect of disulfiram on HIV positive patients.
    Hørding M; Gøtzsche PC; Bygbjerg IC; Christensen LD; Faber V
    Int J Immunopharmacol; 1990; 12(2):145-7. PubMed ID: 2184133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunomodulating action of bestatin in the combined therapy of bladder cancer patients].
    Neprina GS; Panteleeva ES; Vatin OE; Kariakin OB
    Urol Nefrol (Mosk); 1994; (2):34-8. PubMed ID: 8017004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of small molecular microbial products modulating immune responses and bestatin.
    Umezawa H
    Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
    Blomgren H; Edsmyr F; Esposti PL; Näslund I
    Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
    Blomgren H; Strender LE; Edsmyr F
    Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function.
    Mathé G
    Biomed Pharmacother; 1991; 45(2-3):49-54. PubMed ID: 1912369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of bestatin in hydatidiform mole.
    Ho PC; Wong LC; Lawton JW; Ma HK
    Cancer Immunol Immunother; 1990; 31(3):187-90. PubMed ID: 2186854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic acid treatment of HIV infection: no significant effect in a pilot trial.
    Hørding M; Christensen KC; Faber V
    Scand J Infect Dis; 1990; 22(6):649-52. PubMed ID: 2284572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulating properties of bestatin in cancer patients. A phase II trial.
    Mathé G; Umezawa H; Misset JL; Brienza S; Canon C; Musset M; Reizenstein P
    Biomed Pharmacother; 1986; 40(10):379-82. PubMed ID: 3495299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
    Bourinbaiar AS; Lee-Huang S; Krasinski K; Borkowsky W
    Biomed Pharmacother; 1994; 48(2):55-61. PubMed ID: 7919106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patients.
    Blomgren H; Edsmyr F; von Stedingk LV; Wasserman J
    Biomed Pharmacother; 1986; 40(2):50-4. PubMed ID: 3756312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
    Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
    Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.
    Morikawa K; Morikawa S; Nakano A; Oseko F
    Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.
    Ichinose Y; Genka K; Koike T; Kato H; Watanabe Y; Mori T; Iioka S; Sakuma A; Ohta M;
    J Natl Cancer Inst; 2003 Apr; 95(8):605-10. PubMed ID: 12697853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of clinical studies of bestatin.
    Oka S
    Recent Results Cancer Res; 1980; 75():126-32. PubMed ID: 7015425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.